Empirical Antibiotic and Outcome in Community-onset Bacteremia

Empirical Antibiotic and Outcome in Community-onset Bacteremia Caused by Third Generation Cephalosporin Resistant Enterobacteriaceae

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03765749

Enrollment

108

Registered

2018-12-05

Start date

2018-11-22

Completion date

2021-12-31

Last updated

2022-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bacteremia

Brief summary

Empirical antibiotic and outcome in Community-onset Bacteremia Caused by third generation cephalosporin resistant Enterobacteriaceae

Detailed description

Prospective cohort study is conducted for monitoring outcomes and risk factors among community-onset bacteremia caused by third generation cephalosporin resistant enterobacteriaceae. Primary endpoint is mortality rate among those who received initially inappropriate antimicrobial which switch to appropriate antimicrobial later when culture and antimicrobial susceptibility test reported among community-onset bacteremia caused by third generation cephalosporin resistant enterobacteriaceae.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patient with Community-onset Bacteremia Caused by third generation cephalosporin resistant Enterobacteriaceae. Age \> 18 years

Exclusion criteria

* Pregnancy * Polymicrobial infection

Design outcomes

Primary

Measure	Time frame
Mortality rate among community-onset bacteremia caused by third generation cephalosporin resistant enterobacteriaceae	January 2018 - march 2019

Countries

Thailand

Outcome results